Lori Cohen, Head of Greenberg Traurig’s Trial Practice, Chosen as a National Law Journal 2016 ‘Winning Litigator’
New York, NY (PRWEB) December 07, 2016 -- Lori G. Cohen, who chairs the Pharmaceutical, Medical Device & Health Care Litigation Practice and the Trial Practice Group at global law firm Greenberg Traurig, LLP, was chosen by The National Law Journal as one of its “Winning Litigators 2016.” According to the publication, which featured Cohen in a special section published Dec. 5, she was selected based on her role in a recent two-month pelvic mesh trial that resulted in a complete defense verdict.
Cohen secured the defense win in February 2016 on behalf of Greenberg Traurig client C.R. Bard Inc., in Sherrer v. Boston Scientific, et al., Case Number 1216-CV27879, in the 16th Judicial Circuit of Missouri. The National Law Journal feature noted that the jury trial took place in a traditionally plaintiff-friendly venue. In addition to Cohen, key trial team members included Shareholder Cliff Merrell and associates Marcella C. Ducca, Sean Jessee, and Sara Deskins Tucker, as well as co-counsel Robert Adams and Hildy Sastre, partners at Shook, Hardy & Bacon.
“Lori is a tireless advocate for her clients and this victory and the dozens of others that came before it are a true testament to that. As always, she was able to effectively explain incredibly complex materials to the jury and convince them that her client was not at fault,” said Philip R. Sellinger, co-chair of the firm’s Global Litigation Practice.
“It is no surprise that Lori was selected for this honor,” said Alan Mansfield, co-chair of the firm’s Global Litigation Practice. “She is a trial lawyer of the highest caliber, and her ability to win over a jury in any setting is an incredible asset to her clients.”
Greenberg Traurig serves as national coordinating counsel and trial counsel for C.R. Bard, a Fortune 500 medical device manufacturer of women’s health products, in the national and international pelvic mesh litigation. The Sherrer trial began on Nov. 30, 2015, and the jury began deliberations on Feb. 1, 2016. On the afternoon of Feb. 2, 2016, the jury announced a complete defense verdict for C.R. Bard and co-defendant Boston Scientific. This was the first pelvic mesh trial to involve two different manufacturers and the first in Missouri state court. The plaintiff requested $28 million in compensatory damages, claiming that the companies' pelvic mesh implants rendered her incontinent and suffering from pain and other ailments. The plaintiff also sought punitive damages against both defendants.
Cohen has a national litigation practice focusing on product liability litigation and specifically, medical device and pharmaceutical litigation. She is widely recognized for her trial skills, and the Sherrer verdict is her 57th defense verdict at trial. Cohen has also been selected as a Law360 2016 Trial MVP, a Law360 2015 "Trial Ace," and a Law360 2012 "Top Female Trial Attorney.” She has been recognized by The National Law Journal as one of "The 50 Most Influential Women Lawyers in America." She has also been recognized by Georgia Super Lawyers magazine as one of its "Top 10 Georgia Super Lawyers" for the last four years, and one of the "Top 100 Georgia Super Lawyers" and "Top 50 Female Georgia Super Lawyers" for the last 12 years. Cohen was one of a very small group of attorneys selected nationally for inclusion in the 2010-2016 editions of Chambers and Partners USA Guide's National Pharmaceutical Industry Products Liability Table.
About Greenberg Traurig’s Pharmaceutical, Medical Device & Health Care Litigation Practice
The Pharmaceutical, Medical Device & Health Care Litigation Practice is an integral part of the firm’s 600-plus member national Litigation Practice. The team is nationally recognized for its dynamic courtroom presence, responsiveness to clients, and deep subject matter knowledge. Recent recognitions include national rankings for 2016 “Products Liability & Mass Torts” from Chambers USA Guide; national rankings for 2016 “Practice Liability & Mass Torts Defense: Pharmaceuticals and Medical Devices” from The Legal 500 United States; and being named the Products Liability/Mass Torts Litigation Department of the Year by the Daily Report in 2013, 2015 and 2016. In addition, Greenberg Traurig is recognized as a "Product Liability Litigation Standout" in the BTI Litigation Outlook 2017 published by BTI Consulting Group.
About Greenberg Traurig’s Trial Practice
Greenberg Traurig's Trial Practice is a multi-disciplinary group of experienced trial attorneys who regularly try complex cases in nearly every state and federal court throughout the country. At times, members of the Trial Practice are also called on to step in at the last minute in complex, risky trials in which the litigation was previously handled by prior counsel. They have the in-house technological capabilities to swiftly and efficiently prepare for and handle multiple trials simultaneously and can transition seamlessly from one trial to the next if necessary. The Trial Practice is an integral part of the firm’s Litigation Practice, comprised of more than 600 litigators across the U.S. and abroad.
About Greenberg Traurig, LLP
Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 2,000 attorneys serving clients from 38 offices in the United States, Latin America, Europe, Asia, and the Middle East. The firm is No. 1 on the 2015 Law360 Most Charitable Firms list, second largest in the U.S. on the 2016 Law360 400, Top 20 on the 2015 Am Law Global 100, and among the 2016 BTI Brand Elite. More information at: http://www.gtlaw.com.
Lourdes Brezo Martinez, Greenberg Traurig, +1 (212) 801-2131, [email protected]
Share this article